University of Mississippi Medical Center Joins the Cardiometabolic Center Alliance as a Charter Member
The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is honored to announce the addition of University of Mississippi Medical Center (UMMC) as a Charter Member of the Alliance.
As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D), and related cardiovascular (CV) and renal comorbidities, the CMCA considers UMMC an important member of the Alliance.
“The addition of the University of Mississippi Medical Center team to the Cardiometabolic Alliance will greatly benefit our mission to improve the quality of care and outcomes for individuals living with Cardiometabolic disease across the country. UMMC is a leader in providing far-reaching, comprehensive care to the patient population they serve across the state of Mississippi. By joining our efforts with UMMC, we can expect to gain a deeper understanding as to even more ways to deliver top quality, team-based care and reduce the risk of complications to those who need it most” said Mikhail Kosiborod MD, Cardiometabolic Center Alliance Executive Director.
“UMMC is very pleased to become a member of the Cardiometabolic Center Alliance and be a part of this national initiative to offer high-quality, comprehensive and multidisciplinary care for our patients with Type 2 diabetes and cardiovascular disease,” said Elizabeth Fryoux MD, Lead Physician of the UMMC Cardiometabolic Center. “Our goal is to ensure these patients receive optimal guideline directed medical therapy, reduce adverse events and significantly improve patient outcomes. We look forward to collaborating with CMCA to provide the most effective care for the patients of Mississippi.”
Alliance members will adopt and implement a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, MO. Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes. These results are made possible by a unified team of clinicians from across the disease continuum, who focus on holistic, guideline-directed preventative care. Through their participation, Alliance members will also contribute to a national registry that will track treatment patterns and quality of care. As the Alliance enhances its capabilities, improves processes, and expands research opportunities on a national scale, the ultimate goal is improved patient outcomes.
About the University of Mississippi Medical Center
UMMC is the state’s only academic medical center. Its education, research and health care missions share the objectives of improving the health of the state’s population and eliminating health disparities.
Located in Jackson, UMMC encompasses seven health science schools, including medicine, nursing, health related professions, dentistry, pharmacy, graduate studies and population health. The Medical Center’s health care enterprise includes the state’s only Level I trauma center, only children’s hospital, and only organ and bone marrow transplant program. The Medical Center also is home to a Telehealth Center of Excellence, one of two in the nation. For more information, visit www.umc.edu or view news and featured stories produced by UMMC Communications and Marketing.